Literature DB >> 24292748

Increased expression of HBZ and Foxp3 mRNA in bronchoalveolar lavage cells taken from human T-lymphotropic virus type 1-associated lung disorder patients.

Yuko Nakayama1, Yoriko Yamazato, Maki Tamayose, Eriko Atsumi, Satomi Yara, Futoshi Higa, Masao Tateyama, Jiro Fujita.   

Abstract

OBJECTIVE: Human T-lymphotropic virus type 1 (HTLV-I) causes adult T-cell leukemia/lymphoma (ATLL), and is associated with chronic inflammatory diseases, including inflammatory pulmonary diseases. HTLV-I bZIP factor (HBZ), which is expressed in all adult T-cell leukemia cells, plays a critical role in the development of lymphoma and systemic inflammation. HTLV-I is harbored by CD4(+) T cells that express forkhead box P3 (Foxp3), and HBZ interacts with Foxp3. This study investigated the chest computed tomography (CT) findings and expression of HBZ and Foxp3 in the bronchoalveolar lavage (BAL) cells from patients with HTLV-I-associated lung disorders.
METHODS: CT scans obtained from 37 patients (10 men and 27 women, aged 37-77 years) with HTLV-I-associated lung disorders were retrospectively evaluated. The expression levels of HBZ and Foxp3 mRNA in BAL cells and the levels of inflammatory cytokines in the BAL fluid (BALF) from patients were compared with those in control subjects.
RESULTS: CT scans frequently revealed a diffuse panbronchiolitis (DPB)-like pattern, along with a nonspecific interstitial pneumonia (NSIP) pattern. An analysis of the BALF revealed lymphocytosis and increased expression of HBZ mRNA in patients with HTLV-I-associated lung disorders. The expression of Foxp3 mRNA positively correlated with the percentages of lymphocytes present in the BALF. The inflammatory cytokine and IL-10 levels were significantly increased in the BALF from patients with HTLV-I-associated lung disorders.
CONCLUSION: The NSIP pattern may be a manifestation of pulmonary involvement in HTLV-I-infected patients, as is the DPB-like pattern. HBZ and Foxp3 likely have a role in the development of lung inflammation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24292748     DOI: 10.2169/internalmedicine.52.0845

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  7 in total

1.  Effectiveness of Combined Therapy with Pirfenidone and Erythromycin for Unclassifiable Interstitial Pneumonia Induced by HTLV-1-associated Bronchioloalveolar Disorder (HABA).

Authors:  Naoko Yokohori; Akitoshi Sato; Mizue Hasegawa; Hideki Katsura; Kenzo Hiroshima; Tamiko Takemura
Journal:  Intern Med       Date:  2017-01-01       Impact factor: 1.271

2.  CT Chest and pulmonary functional changes in patients with HTLV-associated myelopathy in the Eastern Brazilian Amazon.

Authors:  Luiz Fábio Magno Falcão; Aline Semblano Carreira Falcão; Rita Catarina Medeiros Sousa; Waldônio de Brito Vieira; Robson Tadachi Moraes de Oliveira; Valéria Marques Ferreira Normando; George Alberto da Silva Dias; Marcio Clementino de Souza Santos; Rodrigo Santiago Barbosa Rocha; Gilberto Toshimitsu Yoshikawa; Roberta Vilela Lopes Koyama; Satomi Fujihara; Víctor Augusto Cavaleiro Corrêa; Hellen Thais Fuzii; Juarez Antônio Simões Quaresma
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

Review 3.  Human T Lymphotropic Virus and Pulmonary Diseases.

Authors:  Apio R N Dias; Luiz F M Falcão; Aline S C Falcão; Valéria M F Normando; Juarez A S Quaresma
Journal:  Front Microbiol       Date:  2018-08-14       Impact factor: 5.640

Review 4.  Human T-cell leukaemia virus type 1 associated pulmonary disease: clinical and pathological features of an under-recognised complication of HTLV-1 infection.

Authors:  Lloyd Einsiedel; Fabian Chiong; Hubertus Jersmann; Graham P Taylor
Journal:  Retrovirology       Date:  2021-01-06       Impact factor: 4.602

Review 5.  Extracellular Vesicles in HTLV-1 Communication: The Story of an Invisible Messenger.

Authors:  Sarah Al Sharif; Daniel O Pinto; Gifty A Mensah; Fatemeh Dehbandi; Pooja Khatkar; Yuriy Kim; Heather Branscome; Fatah Kashanchi
Journal:  Viruses       Date:  2020-12-10       Impact factor: 5.048

6.  Computed tomography with 6-year follow-up demonstrates the evolution of HTLV-1 related lung injuries: A cohort study.

Authors:  Apio Ricardo Nazareth Dias; Waldonio de Brito Vieira; Valéria Marques Ferreira Normando; Karen Margarete Vieira da Silva Franco; Aline Semblano Carreira Falcão; Rita Catarina Medeiros de Sousa; Hellen Thais Fuzii; Luiz Fábio Magno Falcão; Juarez Antônio Simões Quaresma
Journal:  PLoS One       Date:  2021-12-29       Impact factor: 3.240

Review 7.  An Overview of Human T-Lymphotropic Virus Type 1 Lung Injury.

Authors:  Ápio Ricardo Nazareth Dias; Luiz Fábio Magno Falcão; Juarez Antônio Simões Quaresma
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.